Showing results (811-820 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|June 22, 2012
Survivin the battle against immunosuppressionEdwin R Manuel, Céline A Blache, Joshua D I Ellenhorn, et al.
Oncoimmunology|June 22, 2012
Enhanced 15-lipoxygenase activity and elevated eicosanoid production in kidney tumor microenvironment contribute to the inflammation and immune suppressionSergei Kusmartsev
Oncoimmunology|June 22, 2012
FOXO3: A master switch for regulating tolerance and immunity in dendritic cellsStephanie K Watkins, Arthur A Hurwitz
Oncoimmunology|June 22, 2012
Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?Michele Sommariva, Loris De Cecco, Elda Tagliabue, et al.
Oncoimmunology|August 21, 2025
Differential distribution of immune checkpoints across molecular subtypes of colorectal cancerSofia Edin, Björn Gylling, Xingru Li, et al.
Oncoimmunology|March 27, 2023
CD25bright NK cells display superior function and metabolic activity under regulatory T cell-mediated suppressionZiqing Chen, Le Tong, Shi Yong Neo, et al.
Oncoimmunology|November 10, 2022
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibodyJessica D Weaver, Edward C Stack, Joshua A Buggé, et al.
Oncoimmunology|March 6, 2023
Analysis of RBP expression and binding sites identifies PTBP1 as a regulator of CD19 expression in B-ALLNicole Ziegler, Mariela Cortés-López, Francesca Alt, et al.
Oncoimmunology|March 6, 2023
Trial watch: Toll-like receptor ligands in cancer therapyJulie Le Naour, Guido Kroemer
Oncoimmunology|November 17, 2022
Chemokine switch regulated by TGF-β1 in cancer-associated fibroblast subsets determines the efficacy of chemo-immunotherapyAngélique Vienot, Jean-René Pallandre, Elodie Renaude, et al.
Pageof 379